Kiniksa Pharmaceuticals, Ltd. (KNSA) Prices 8.48M Share IPO at $18/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering
May 23, 2018 9:13 PM EDTHAMILTON, Bermuda, May 23, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Kiniksa) announced today the pricing of its initial public offering of 8,477,777 Class A common shares at a public offering price of $18.00 per share, before underwriting discounts and commissions. The gross proceeds to Kiniksa from this offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $152.6 million. In addition, Kiniksa has granted the underwriters a 30-day option to purchase up to 1,271,666 additional Class A common shares at the initial public offering price, less underwriting discounts and commissions. The shares are expected to... More
